Succinilcolina Altian

Succinilcolina Altian may be available in the countries listed below.

Ingredient matches for Succinilcolina Altian

Suxamethonium Chloride

Suxamethonium Chloride is reported as an ingredient of Succinilcolina Altian in the following countries:

• Guatemala

International Drug Name Search

Fluconazol Baxter

Fluconazol Baxter may be available in the countries listed below.

Ingredient matches for Fluconazol Baxter

Fluconazole

Fluconazole is reported as an ingredient of Fluconazol Baxter in the following countries:

• Netherlands

International Drug Name Search

Aminophyllin Amino

Aminophyllin Amino may be available in the countries listed below.

Ingredient matches for Aminophyllin Amino

Aminophylline

Aminophylline is reported as an ingredient of Aminophyllin Amino in the following countries:

• Switzerland

International Drug Name Search

Aquastin

Aquastin may be available in the countries listed below.

Ingredient matches for Aquastin

Aluminium Hydroxide

Aluminium Hydroxide is reported as an ingredient of Aquastin in the following countries:

• Japan

Magnesium Hydroxide

Magnesium Hydroxide is reported as an ingredient of Aquastin in the following countries:

• Japan

International Drug Name Search

Triamtereen Sandoz

Triamtereen Sandoz may be available in the countries listed below.

Ingredient matches for Triamtereen Sandoz

Triamterene

Triamterene is reported as an ingredient of Triamtereen Sandoz in the following countries:

• Netherlands

International Drug Name Search

Dulcolax

Pronunciation: bis-AK-oh-dil
Generic Name: Bisacodyl
Brand Name: Examples include Correctol and Dulcolax

Dulcolax is used for:

Relieving occasional constipation and irregularity. It may also be used for other conditions as determined by your doctor.

Dulcolax is a stimulant laxative. It acts directly on the bowels, stimulating the bowel muscles to cause a bowel movement.

Do NOT use Dulcolax if:

• you are allergic to any ingredient in Dulcolax


• you have severe stomach pain; appendicitis; severe constipation; stomach, intestinal, or rectal bleeding; or intestinal blockage


• you cannot swallow without chewing


• you are having abdominal surgery

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dulcolax:

Tell your health care provider if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have heart failure, abnormal levels of fluids or electrolytes in your body, nausea, vomiting, or undiagnosed stomach pain

Some MEDICINES MAY INTERACT with Dulcolax. However, no specific interactions with Dulcolax are known at this time.

Ask your health care provider if Dulcolax may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dulcolax:

Use Dulcolax as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Dulcolax by mouth with or without food.


• Take Dulcolax with a full glass of water (8 oz/240 mL).


• Drinking extra fluids while you are taking Dulcolax is recommended. Check with your doctor for instructions.


• Swallow Dulcolax whole. Do not break, crush, or chew before swallowing.


• Do not take Dulcolax within 1 hour after taking an antacid or milk.


• If you miss a dose of Dulcolax and are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dulcolax.

Important safety information:

• Do not use for longer than 1 week without checking with your doctor. Using Dulcolax for a long time may result in loss of normal bowel function.


• Do not take additional laxatives or stool softeners with Dulcolax unless directed by your doctor.


• Rectal bleeding or failure to have a bowel movement within 12 hours after use of a laxative may be a sign of a serious condition. Stop use and contact your doctor.


• If you develop nausea, vomiting, or stomach pain, stop using Dulcolax and check with your doctor.


• If you notice a sudden change in bowel habits that lasts for 2 weeks or more, do not continue using Dulcolax. Instead, check with your doctor.


• Use Dulcolax with caution in the ELDERLY; they may be more sensitive to its effects.


• Dulcolax should not be used in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dulcolax while pregnant. It is not known if Dulcolax is found in breast milk. If you are or will be breast-feeding take Dulcolax, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Dulcolax:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Cramps; faintness; stomach discomfort.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dulcolax side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include diarrhea; stomach cramps.

Proper storage of Dulcolax:

Store Dulcolax at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store in a tightly closed container away from heat, moisture, and light. Do not store in the bathroom. Keep Dulcolax out of the reach of children and away from pets.

General information:

• If you have any questions about Dulcolax, please talk with your doctor, pharmacist, or other health care provider.


• Dulcolax is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dulcolax. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dulcolax resources

• Dulcolax Side Effects (in more detail)
• Dulcolax Use in Pregnancy & Breastfeeding
• Drug Images
• Dulcolax Drug Interactions
• Dulcolax Support Group
• 8 Reviews for Dulcolax - Add your own review/rating

Compare Dulcolax with other medications

• Bowel Preparation
• Constipation

Fudosteine

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0013189-98-5

Chemical Formula

C6-H13-N-O3-S

Molecular Weight

179

Therapeutic Category

Expectorant

Chemical Names

(-)-R-2-Amino-3-(3-hydroxypropylthio)propionic acid (JAN)

(-)-3-[(3-Hydroxypropyl)thiol]-L-alanine (WHO)

L-Cysteine, S-(3-hydroxypropyl)-

Foreign Names

• Fudosteinum (Latin)
• Fudostein (German)
• Fudostéine (French)
• Fudosteina (Spanish)

Generic Names

• Fudosteine (OS: JAN)
• SS-320A (IS)
• UNII-UR9VPI71PT (IS)

Brand Names

• Cleanal
  Tanabe Mitsubishi, Japan



• Spelear
  Hisamitsu, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Alegain

Alegain may be available in the countries listed below.

Ingredient matches for Alegain

Epinastine

Epinastine hydrochloride (a derivative of Epinastine) is reported as an ingredient of Alegain in the following countries:

• Japan

International Drug Name Search

Convadien

Convadien may be available in the countries listed below.

Ingredient matches for Convadien

Dienogest

Dienogest is reported as an ingredient of Convadien in the following countries:

• Luxembourg

Estradiol

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Convadien in the following countries:

• Luxembourg

International Drug Name Search

Equistro

Equistro may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Equistro

Chondroitin Polysulfate

Chondroitin Polysulfate is reported as an ingredient of Equistro in the following countries:

• France

Cyanocobalamin

Cyanocobalamin is reported as an ingredient of Equistro in the following countries:

• France

Dexpanthenol

Dexpanthenol is reported as an ingredient of Equistro in the following countries:

• France

Glucosamine

Glucosamine hydrochloride (a derivative of Glucosamine) is reported as an ingredient of Equistro in the following countries:

• France

Magnesium

Magnesium is reported as an ingredient of Equistro in the following countries:

• France

Sodium Selenite

Sodium Selenite is reported as an ingredient of Equistro in the following countries:

• France

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Equistro in the following countries:

• France

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Equistro in the following countries:

• France

Zinc Oxide

Zinc is reported as an ingredient of Equistro in the following countries:

• France

International Drug Name Search

Hydromorphon-dura

Hydromorphon-dura may be available in the countries listed below.

Ingredient matches for Hydromorphon-dura

Hydromorphone

Hydromorphone hydrochloride (a derivative of Hydromorphone) is reported as an ingredient of Hydromorphon-dura in the following countries:

• Germany

International Drug Name Search

Magnol

Magnol may be available in the countries listed below.

Ingredient matches for Magnol

Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Magnol in the following countries:

• Mexico

International Drug Name Search

Oxsoralen-Ultra Soft-Gelatin Capsules

Pronunciation: meth-OX-a-len
Generic Name: Methoxsalen
Brand Name: Oxsoralen-Ultra

Oxsoralen-Ultra Soft-Gelatin Capsules, used along with ultraviolet (UV) radiation, can cause serious damage to the eyes and skin, including skin cancer. It should only be used in patients with severe, disabling psoriasis that has not responded to other treatment. Discuss any questions or concerns with your doctor.

Do not switch brands of Oxsoralen-Ultra Soft-Gelatin Capsules (hard-gelatin and soft-gelatin capsules) without talking with your doctor.

Oxsoralen-Ultra Soft-Gelatin Capsules is used for:

Treating severe, disabling psoriasis. It is used along with UV radiation.

Oxsoralen-Ultra Soft-Gelatin Capsules is a psoralen. It works by making the skin more sensitive to UV light. It appears that this sensitivity results in damage to the skin cells when UV light treatment is given. Damaged skin cells grow more slowly and the rate of tissue growth is reduced.

Do NOT use Oxsoralen-Ultra Soft-Gelatin Capsules if:

• you are allergic to any ingredient in Oxsoralen-Ultra Soft-Gelatin Capsules or to similar medicines


• you have a history of a light-sensitive condition (eg, albinism, lupus, porphyria, xeroderma pigmentosum)


• you have aphakia (you do not have a lens in your eye)


• you have a history of melanoma or certain other types of skin cancer


• your skin is sensitive to the sun or light

Contact your doctor or health care provider right away if any of these apply to you.

Before using Oxsoralen-Ultra Soft-Gelatin Capsules:

Some medical conditions may interact with Oxsoralen-Ultra Soft-Gelatin Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of skin cancer or other skin conditions


• if you have an infection, cataracts or other eye problems, liver or kidney problems, heart disease or blood vessel disease, high blood pressure, or stomach problems


• if you have had x-ray, grenz ray, arsenic, or radiation therapy


• if you are unable to stand for long periods of time or if you do not tolerate heat well

Some MEDICINES MAY INTERACT with Oxsoralen-Ultra Soft-Gelatin Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anthralin, coal tar or coal tar derivatives, griseofulvin, nalidixic acid, phenothiazines (eg, chlorpromazine), quinolone antibiotics (eg, levofloxacin), sulfonamides (eg, sulfamethoxazole), sulfonylureas (eg, glipizide), tetracycline antibiotics (eg, doxycycline), or thiazides (eg, hydrochlorothiazide) because they may increase the risk of severe sunburn


• Hydantoins (eg, phenytoin) because they may decrease the effectiveness of Oxsoralen-Ultra Soft-Gelatin Capsules


• Cyclosporine because the risk of its side effects may be increased by Oxsoralen-Ultra Soft-Gelatin Capsules

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oxsoralen-Ultra Soft-Gelatin Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Oxsoralen-Ultra Soft-Gelatin Capsules:

Use Oxsoralen-Ultra Soft-Gelatin Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Oxsoralen-Ultra Soft-Gelatin Capsules. Talk to your pharmacist if you have questions about this information.


• Take Oxsoralen-Ultra Soft-Gelatin Capsules by mouth with low-fat food or milk.


• Take Oxsoralen-Ultra Soft-Gelatin Capsules before ultraviolet A (UVA) exposure according to your doctor's instructions. The amount of time you take Oxsoralen-Ultra Soft-Gelatin Capsules before UVA exposure depends on the condition being treated.


• If nausea occurs, take Oxsoralen-Ultra Soft-Gelatin Capsules in 2 divided doses 30 minutes apart.


• If you miss a dose of Oxsoralen-Ultra Soft-Gelatin Capsules, check with your doctor because it may be necessary to reschedule your light therapy.

Ask your health care provider any questions you may have about how to use Oxsoralen-Ultra Soft-Gelatin Capsules.

Important safety information:

• Oxsoralen-Ultra Soft-Gelatin Capsules may cause dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Oxsoralen-Ultra Soft-Gelatin Capsules. Using Oxsoralen-Ultra Soft-Gelatin Capsules alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• Different brands of this drug are not interchangeable because they have significant differences in how they act in the body.


• Do not sunbathe or use a tanning booth for at least 24 hours before receiving Oxsoralen-Ultra Soft-Gelatin Capsules and light therapy. Do not sunbathe or use a tanning booth for at least 48 hours after your treatment. Check with your doctor before you sunbathe or use a tanning booth.


• After your treatment, avoid any exposure to sunlight for at least 8 hours. This includes indirect light through a window or on cloudy days. If you cannot avoid exposure to sunlight, wear protective clothing, or use a sunscreen with a sun protective factor (SPF) of 15 or greater, as directed by your doctor. Protect all areas of the body, including lips, from sun exposure. Do not apply sunscreen to the psoriasis areas until after you have received UV treatment.


• Serious burns from either UV light or sunlight (even through a window glass) can occur if you use more than the recommended dose of Oxsoralen-Ultra Soft-Gelatin Capsules or if you use it for longer than prescribed.


• During treatment with Oxsoralen-Ultra Soft-Gelatin Capsules and UVA light, wear total UVA absorbing/blocking goggles designed to provide maximal protection of the eyes. This may decrease the risk of cataracts from Oxsoralen-Ultra Soft-Gelatin Capsules.


• To protect your eyes, wear special wrap-around sunglasses that absorb UVA during daylight hours for 24 hours after taking Oxsoralen-Ultra Soft-Gelatin Capsules. Regular sunglasses do not adequately protect your eyes because they allow light to enter from the side.


• You will need to have an eye exam before starting Oxsoralen-Ultra Soft-Gelatin Capsules. You will also need to have an eye exam once per year thereafter.


• Protect stomach skin, breasts, genitals, and other sensitive areas for about one third of the exposure time until tanning occurs. Unless affected by disease, male genitals should be shielded. Discuss any questions with your doctor.


• Exposure to sunlight or UV radiation may cause early aging of the skin.


• Oxsoralen-Ultra Soft-Gelatin Capsules increases the risk of skin cancer. Discuss any questions or concerns with your doctor.


• Tell your doctor if you use certain antibacterial or deodorant soaps or certain dyes (eg, methyl orange, methylene blue, rose bengal, toluidine blue). They may increase the risk of severe sunburn with Oxsoralen-Ultra Soft-Gelatin Capsules.


• Itching may be relieved by applying a bland moisturizing cream or lotion. Check with your doctor if itching persists or is severe.


• Tell your doctor if you lose or gain weight while you are using Oxsoralen-Ultra Soft-Gelatin Capsules. Your dose may need to be changed.


• Lab tests, including complete blood cell counts and liver and kidney function tests, may be performed while using Oxsoralen-Ultra Soft-Gelatin Capsules. These tests may be used to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.


• Use Oxsoralen-Ultra Soft-Gelatin Capsules with caution in the ELDERLY; they may be more sensitive to its effects.


• Oxsoralen-Ultra Soft-Gelatin Capsules should be used with extreme caution in CHILDREN; safety and effectiveness have not been confirmed.


• PREGNANCY and BREAST-FEEDING: It is not known if Oxsoralen-Ultra Soft-Gelatin Capsules may cause harm to the fetus. Do not become pregnant while you are using it. If you become pregnant, contact your doctor. You will need to discuss with your doctor the benefits and risks of using Oxsoralen-Ultra Soft-Gelatin Capsules while you are pregnant. It is not known if Oxsoralen-Ultra Soft-Gelatin Capsules is found in breast milk. Do not breast-feed while taking Oxsoralen-Ultra Soft-Gelatin Capsules.

Possible side effects of Oxsoralen-Ultra Soft-Gelatin Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Mild itching; mild, temporary redness of the skin; nausea; nervousness; trouble sleeping.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blistering; burns on the treated area from overexposure to UVA or sunlight; change in the appearance of a mole; depression; new growth on the skin; severe itching or redness of the skin; severe or persistent dizziness; unusual swelling or blistering of the skin.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Oxsoralen-Ultra side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Oxsoralen-Ultra Soft-Gelatin Capsules:

Store Oxsoralen-Ultra Soft-Gelatin Capsules at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oxsoralen-Ultra Soft-Gelatin Capsules out of the reach of children and away from pets.

General information:

• If you have any questions about Oxsoralen-Ultra Soft-Gelatin Capsules, please talk with your doctor, pharmacist, or other health care provider.


• Oxsoralen-Ultra Soft-Gelatin Capsules is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Oxsoralen-Ultra Soft-Gelatin Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Oxsoralen-Ultra resources

• Oxsoralen-Ultra Side Effects (in more detail)
• Oxsoralen-Ultra Use in Pregnancy & Breastfeeding
• Drug Images
• Oxsoralen-Ultra Drug Interactions
• Oxsoralen-Ultra Support Group
• 0 Reviews for Oxsoralen-Ultra - Add your own review/rating

Compare Oxsoralen-Ultra with other medications

• Psoriasis

Salofalk

In the US, Salofalk (mesalamine systemic) is a member of the drug class 5-aminosalicylates and is used to treat Crohn's Disease - Maintenance, Ulcerative Colitis - Active and Ulcerative Colitis - Maintenance.

US matches:

• Salofalk Rectal

UK matches:

• Salofalk 1.5g gastro-resistant prolonged release granules
• Salofalk 1000mg Granules
• Salofalk 500mg gastro-resistant prolonged release granules
• Salofalk Enema 2g
• Salofalk Rectal Foam 1g
• Salofalk Suppositories 500mg
• Salofalk 1.5g gastro-resistant prolonged release granules (SPC)
• Salofalk 1000mg gastro-resistant prolonged release granules (SPC)
• Salofalk 1g Suppositories (SPC)
• Salofalk 250mg Tablets (SPC)
• Salofalk 500mg gastro-resistant prolonged release granules (SPC)
• Salofalk 500mg gastro-resistant tablets (SPC)
• Salofalk Enema 2g (Dr. Falk Pharma UK Ltd) (SPC)
• Salofalk Rectal Foam 1g (SPC)
• Salofalk Suppositories 500mg (Dr. Falk Pharma UK Ltd) (SPC)

Ingredient matches for Salofalk

Mesalazine

Mesalazine is reported as an ingredient of Salofalk in the following countries:

• Argentina


• Australia


• Austria


• Bosnia & Herzegowina


• Bulgaria


• Canada


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Estonia


• Finland


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Latvia


• Lithuania


• Malaysia


• Malta


• Mexico


• Netherlands


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• Thailand


• Turkey


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.